This is a disambiguation page — a navigational aid which lists other pages that might otherwise share the same title. If an article link referred you here, you might want to go back and fix it to point directly to the intended page.
Ataxia MJD Research Project, Inc. is now accepting proposals for a $50,000 grant for research aimed at understanding the pathogenesis and development of a treatment or cure for Machado-Joseph Disease (SCA3, MJD).
MJD is somewhat similar to Huntington's Disease, Parkinson's Disease and ALS (Lou Gehrig's Disease).
MJD often affects individuals of Portuguese descent but it is a world-wide problem.
Type III MJD patients have an onset between 40 and 70 years of age, a relatively slow progression, and some muscle twitching, muscle atrophy, and unpleasant sensations such as numbness, tingling, cramps, and pain in the hands, feet, and limbs.
MJD is an inherited, autosomal dominant disease, meaning that if a child inherits one copy of the defective gene from either parent, the child will develop symptoms of the disease.
One trait of MJD and other triplet repeat diseases is a phenomenon called anticipation, in which the children of affected parents tend to develop symptoms of the disease much earlier in life, have a faster progression of the disease, and experience more severe symptoms.
Feeds |
Contact